Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Collier, F, Ellul, S, Juonala, M, Ponsonby, A-L, Vuillermin, P, Saffery, R, Burgner, D, Barwon Infant Study Investigator Group.
Glycoprotein acetyls (GlycA) at 12 months are associated with high-sensitivity C-reactive protein and early life inflammatory immune measures..
Pediatr Res
85(5)
:
584 -585
2019
view publication
Fraser, BJ, Blizzard, L, Tomkinson, GR, Lycett, K, Wake, M, Burgner, D, Ranganathan, S, Juonala, M, Dwyer, T, Venn, AJ, et al.
The great leap backward: changes in the jumping performance of Australian children aged 11-12-years between 1985 and 2015..
J Sports Sci
37(7)
:
748 -754
2019
view publication
Versteege, T, Karyanti, MR, Septiani, W, Widjanarko, AL, Idris, NS, Hendarto, A, Grobbee, DE, Burgner, D, Uiterwaal, CSPM, Bruijning-Verhagen, PCJL.
Increased Carotid Intima-Media Thickness in Children with a History of Dengue Hemorrhagic Fever..
Am J Trop Med Hyg
100(3)
:
630 -634
2019
view publication
Liu, RS, Wake, M, Grobler, A, Cheung, M, Lycett, K, Ranganathan, S, Edwards, B, Dwyer, T, Azzopardi, P, Juonala, M, et al.
Cross-sectional associations between Ideal Cardiovascular Health scores and vascular phenotypes in 11- to 12-year-olds and their parents: The Longitudinal Study of Australian Children..
Int J Cardiol
277:
258 -265
2019
view publication
Strunk, T, Campbell, C, Burgner, D, Charles, A, French, N, Sharp, M, Simmer, K, Nathan, E, Doherty, D.
Histological chorioamnionitis and developmental outcomes in very preterm infants..
J Perinatol
39(2)
:
321 -330
2019
view publication